Tag: Plans
-
Hexaware Hosts Greater Manchester and West Yorkshire Mayoral Delegation, Deepens Partnership with University of Leeds
Part of the Great North Mayoral Delegation’s visit to India, discussions focused on Hexaware’s UK expansion and planned R&D centers in Leeds and Manchester MUMBAI, India, Oct. 23, 2026 /PRNewswire/ — Hexaware Technologies (NSE: HEXT), an AI-first digital and IT services company, hosted a delega…
-
QFocus Technologies Scales Global Engineering Business, Plans to Triple Workforce in 2027 to Support Growing Customer Demand
BENGALURU, India and SAN FRANCISCO, Oct. 23, 2026 /PRNewswire/ — QFocus Technologies LLC (QFocus), headquartered in the USA, is strengthening its global engineering operations following continued business growth across its key markets. The company has doubled its customer base to include top OEMs a…
-
TraceLink Achieves a Breakthrough with No-Code Supply Chain Agents that Reliably Perform Critical Work in Seconds
The OPUS Brain accelerates agentic work through optimized, verifiable Semantic Inference Plans, with versioned Agent Profiles and operational controls that support reliable performance at scale.BOSTON, October 21, 2026 /PRNewswire/ — TraceLink, the world’s largest Agentic Business Network, today an…
-
Hantec Trader becomes RZR Funded as firm enters new phase of growth
Proprietary trading firm establishes standalone brand ahead of product and market expansion, with an expanded leadership team. No change to conditions for existing traders. EBENE, Mauritius, Oct. 19, 2026 /PRNewswire/ — The proprietar…
-
Avid Organics Announces Plans for First U.S. Manufacturing Facility
Glycine and glycolic acid production targeted for 2028; up to US$50 million planned for U.S. operations through 2035AUSTIN, Texas, Oct. 13, 2026 /PRNewswire/ — Avid Organics Private Limited today announced plans to establish its first manufacturing facility outside India in the United States throug…
-
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetrati…
-
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control.PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNewswire…
-
Cellebrite Initiates Plans to Redomicile in the United States
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 14, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, announced today that the Company’s Board of Directors has authorized Celleb…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.